Palaiseau, France

Anne Coutel-Egros

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Sante. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne Coutel-Egros. Retrieved from https://idiyas.com/inventor/anne-coutel-egros

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Anne Coutel-Egros

Introduction

Anne Coutel-Egros is a notable inventor based in Palaiseau, France. She has made significant contributions to the field of pharmaceuticals, particularly with her work on compositions based on imipyramine. Her innovative approach has led to the development of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Anne Coutel-Egros holds a patent for "Compositions based on imipyramine." This patent reflects her commitment to creating effective pharmaceutical solutions that can improve patient outcomes. With 1 patent to her name, she has established herself as a valuable contributor to the field.

Career Highlights

Throughout her career, Anne has worked with Rhone-Poulenc Santé, a prominent company in the pharmaceutical industry. Her role at the company has allowed her to engage in groundbreaking research and development, further enhancing her skills as an inventor. Her work has not only contributed to her personal achievements but has also had a positive impact on the healthcare sector.

Conclusion

Anne Coutel-Egros exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patent and work at Rhone-Poulenc Santé highlight the importance of inventors in advancing medical science. Her dedication to improving healthcare through her inventions is commendable and serves as an inspiration for future innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…